IDH1 and IDH2: not your typical oncogenes.
Publication
, Journal Article
Reitman, ZJ; Parsons, DW; Yan, H
Published in: Cancer Cell
March 16, 2010
Oncogenes usually increase their normal function when activated. However, seemingly oncogenic mutations in IDH1 and IDH2 reduce their native enzyme activity. In this issue of Cancer Cell, Ward et al. pin down a neomorphic enzyme activity as a possible oncogenic function for these alterations.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Cell
DOI
EISSN
1878-3686
Publication Date
March 16, 2010
Volume
17
Issue
3
Start / End Page
215 / 216
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reitman, Z. J., Parsons, D. W., & Yan, H. (2010). IDH1 and IDH2: not your typical oncogenes. Cancer Cell, 17(3), 215–216. https://doi.org/10.1016/j.ccr.2010.02.024
Reitman, Zachary J., D Williams Parsons, and Hai Yan. “IDH1 and IDH2: not your typical oncogenes.” Cancer Cell 17, no. 3 (March 16, 2010): 215–16. https://doi.org/10.1016/j.ccr.2010.02.024.
Reitman ZJ, Parsons DW, Yan H. IDH1 and IDH2: not your typical oncogenes. Cancer Cell. 2010 Mar 16;17(3):215–6.
Reitman, Zachary J., et al. “IDH1 and IDH2: not your typical oncogenes.” Cancer Cell, vol. 17, no. 3, Mar. 2010, pp. 215–16. Pubmed, doi:10.1016/j.ccr.2010.02.024.
Reitman ZJ, Parsons DW, Yan H. IDH1 and IDH2: not your typical oncogenes. Cancer Cell. 2010 Mar 16;17(3):215–216.
Published In
Cancer Cell
DOI
EISSN
1878-3686
Publication Date
March 16, 2010
Volume
17
Issue
3
Start / End Page
215 / 216
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences